NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial
20 févr. 2024 08h00 HE
|
NMDP
Groundbreaking Trial Seeks to Enhance Blood Cancer Treatment Efficacy and Safety.
NMDP/Be The Match® PTCy Research Levels the Field between Matched and Mismatched Hematopoietic Cell Transplantation
11 déc. 2023 15h00 HE
|
Be The Match
The study shows the practice-changing potential of using mismatched unrelated donors to expand access to all patients regardless of ancestry.
Results of Study on COVID-19 Vaccine Response in Hematopoietic Cell Transplant Patients Published in eClinicalMedicine
24 mai 2023 11h28 HE
|
Be The Match
MINNEAPOLIS, May 24, 2023 (GLOBE NEWSWIRE) -- Results from a joint study between CIBMTR® (Center for International Blood and Marrow Transplant Research®)—a research collaboration between the...
The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® Mark Clinical Trials Day With New Resources and Services for Patients, Researchers, and Industry Sponsors
17 mai 2023 08h12 HE
|
Be The Match
MINNEAPOLIS, May 17, 2023 (GLOBE NEWSWIRE) -- The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® launched a new web resource page and free white paper, “Paving...
Results of Study on Cryopreserved Hematopoietic Stem Cell Grafts By CIBMTR Published in Blood Advances
18 avr. 2023 08h00 HE
|
Be The Match
MINNEAPOLIS, April 18, 2023 (GLOBE NEWSWIRE) -- CIBMTR® (Center for International Blood and Marrow Transplant Research®) announced that the results of a multi-center observational study, around the...
National Marrow Donor Program/Be The Match Continues to Invest in Researchers of Tomorrow and Expands its Philanthropically Funded Research Programs
16 mars 2023 16h08 HE
|
Be The Match
MINNEAPOLIS, March 16, 2023 (GLOBE NEWSWIRE) -- National Marrow Donor Program (NMDP)/Be The Match® announced two recipients of its Amy Strelzer Manasevit Research Program grant for 2023. The grant...
The Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists Will Gather for the 2023 Tandem Meetings
30 nov. 2022 12h00 HE
|
American Society for Transplantation and Cellular Therapy (ASTCT)
CHICAGO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The 2023 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® will connect the international community of hematopoietic...
Dr. Owhofasa Agbedia to Receive the 2021 ASH-CIBMTR-ASTCT Career Development Award
22 juin 2022 11h00 HE
|
American Society for Transplantation and Cellular Therapy (ASTCT)
CHICAGO, June 22, 2022 (GLOBE NEWSWIRE) -- American Society for Transplantation and Cellular Therapy (ASTCT) is pleased to announce that Owhofasa Agbedia, MD, MPH, has been selected by the American...
Incysus Therapeutics Announces Presentations at 2018 ASH and HAPLO Annual Meetings
28 nov. 2018 16h00 HE
|
Incysus Therapeutics, Inc.
NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...